Halkid 200micrograms/ml Oral Solution is indicated for use in children when low doses of haloperidol need to be administered for the treatment of the following conditions:
Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.
Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.
Tic disorders, including Tourette's syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.
For further information please contact us at email@example.com
Go back to Licensed products full list